A blueprint for success: integration of neglected tropical disease control programmes

Trends in Parasitology

Volumn 22, Issue 7, 2006, Pages 313-321

  Lammie, Patrick J ^a   Fenwick, Alan ^b   Utzinger, Jürg ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; DIETHYLCARBAMAZINE; IVERMECTIN; PRAZIQUANTEL; RECOMBINANT VACCINE;

ANCYLOSTOMA DUODENALE; ASCARIS LUMBRICOIDES; CLINICAL TRIAL; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DISEASE TRANSMISSION; FILARIASIS; HEALTH CARE; HEALTH PROGRAM; HELMINTHIASIS; HUMAN; MORBIDITY; NECATOR AMERICANUS; NONHUMAN; PLASMODIUM FALCIPARUM; REVIEW; RISK ASSESSMENT; SCHISTOSOMIASIS; TREATMENT OUTCOME; TRICHURIS; TROPICAL DISEASE;

ANIMALS; FILARIASIS; HELMINTHIASIS; HUMANS; NATIONAL HEALTH PROGRAMS; SCHISTOSOMIASIS; TROPICAL CLIMATE; WORLD HEALTH;

MELINDA;

EID: 33745657253     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2006.05.009     Document Type: Review

References (82)

1. de Silva N.R., et al. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 19 (2003) 547-551
2. Fenwick A., et al. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 19 (2003) 509-515
3. Molyneux D.H., et al. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol. 19 (2003) 516-522
4. Erlanger T.E., et al. Effect of water resource development and management on lymphatic filariasis, and estimates of populations at risk. Am. J. Trop. Med. Hyg. 73 (2005) 523-533
5. WHO (2005) Sixth meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, Geneva, Switzerland, 20-23 September 2005. Wkly. Epidemiol. Rec. 80, 401-408
6. Molyneux D.H., and Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Ann. Trop. Med. Parasitol. 96 Suppl. 2 (2002) S15-S40
7. Steinmann, P. et al. Schistosomiasis and water resources development: systematic review, meta-analysis and estimates of people at risk. Lancet Infect. Dis. (in press)
8. Horton J. Human gastrointestinal helminth infections: are they now neglected diseases?. Trends Parasitol. 19 (2003) 527-531
9. Durrheim D.N., et al. Lymphatic filariasis endemicity - an indicator of poverty?. Trop. Med. Int. Health 9 (2004) 843-845
10. Utzinger J., and Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmacother. 5 (2004) 263-285
11. Hotez P.J., et al. Incorporating a rapid impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med 3 (2006) e102
12. Gyapong J.O., et al. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin. Pharmacother. 6 (2005) 179-200
13. Yu D., et al. Cost-effectiveness analysis of the impacts on infection and morbidity attributable to three chemotherapy schemes against Schistosoma japonicum in hyperendemic areas of the Dongting Lake region, China. Southeast Asian J. Trop. Med. Public Health 33 (2002) 441-457
14. Ramzy R.M.R., et al. Defining the cost of the Egyptian lymphatic filariasis elimination programme. Filaria J. 4 (2005) 7
15. Kabatereine N.B., et al. Soil-transmitted helminthiasis in Uganda: epidemiology and cost of control. Trop. Med. Int. Health 10 (2005) 1187-1189
16. WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech. Rep. Ser. No. 912, 1-57
17. Molyneux D.H., et al. 'Rapid-impact interventions': how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2 (2005) e336
18. Fenwick A. New initiatives against Africa's worms. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 200-207
19. International Task Force for Disease Eradication (1993) Recommendations of the International Task Force for Disease Eradication. MMWR Recomm. Rep. 42, 1-38
20. WHO (2004) Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis. Wkly. Epidemiol. Rec. 79, 358-365
21. Tisch D.J., et al. Mass chemotherapy options to control lymphatic filariasis: a systematic review. Lancet Infect. Dis. 5 (2005) 514-523
22. Melrose W.D., et al. Update on immunological tests for lymphatic filariasis. Trends Parasitol. 20 (2004) 255-257
23. WHO (2005) Global Programme to Eliminate Lymphatic Filariasis. Wkly. Epidemiol. Rec. 80, 202-212
24. Ramzy R.M.R., et al. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367 (2006) 992-999
25. Gyapong J.O. 2.5. Monitoring and evaluation. Am. J. Trop. Med. Hyg. 71 Suppl. 5 (2004) 20-21
26. Bockarie M.J., et al. Mass treatment to eliminate filariasis in Papua New Guinea. N. Engl. J. Med. 347 (2002) 1841-1848
27. Molyneux D.H., and Nantulya V.M. Linking disease control programmes in rural Africa: a pro-poor strategy to reach Abuja targets and millennium development goals. BMJ 328 (2004) 1129-1132
28. Mani T.R., et al. Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme. Trop. Med. Int. Health 9 (2004) 1030-1035
29. Mani T.R., et al. Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India. Trop. Med. Int. Health 7 (2002) 541-548
30. de Silva N.R., et al. Impact of mass chemotherapy for the control of filariasis on geohelminth infections in Sri Lanka. Ann. Trop. Med. Parasitol. 97 (2003) 421-425
31. de Rochars M.B., et al. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. Am. J. Trop. Med. Hyg. 71 (2004) 466-470
32. Oqueka T., et al. Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island. Indonesia. Filaria J. 4 (2005) 5
33. Ottesen E.A., et al. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol. Today 15 (1999) 382-386
34. Stephenson L.S., et al. Malnutrition and parasitic helminth infections. Parasitology 121 Suppl. (2000) S23-S38
35. Hotez P.J., et al. Hookworm infection. N. Engl. J. Med. 351 (2004) 799-807
36. Brooker S., et al. Human hookworm infection in the 21st century. Adv. Parasitol. 58 (2004) 197-288
37. Groll E. Praziquantel. Adv. Pharmacol. Chemother. 20 (1984) 219-238
38. WHO (1985) The control of schistosomiasis: report of a WHO expert committee. WHO Tech. Rep. Ser. No. 728, 1-49
39. Savioli L., et al. Schistosomiasis and soil-transmitted helminth infections: forging control efforts. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 577-579
40. Engels D., et al. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop. 82 (2002) 139-146
41. Katz N. Schistosomiasis control in Brazil. Mem. Inst. Oswaldo Cruz 93 Suppl. 1 (1998) 33-35
42. Zhou X.N., et al. The public health significance and control of schistosomiasis in China - then and now. Acta Trop. 96 (2005) 97-105
43. Kabatereine N.B., et al. Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 208-215
44. Richter J. The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop. 86 (2003) 161-183
45. Koukounari, A. et al. Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. Am. J. Trop. Med. Hyg. (in press)
46. Brooker S., et al. Evaluating the epidemiological impact of national control programmes for helminths. Trends Parasitol. 20 (2004) 537-545
47. Woolhouse M.E.J. Patterns in parasite epidemiology: the peak shift. Parasitol. Today 14 (1998) 428-434
48. de Silva N.R. Impact of mass chemotherapy on the morbidity due to soil-transmitted nematodes. Acta Trop. 86 (2003) 197-214
49. Ezeamama A.E., et al. Functional significance of low-intensity polyparasite helminth infections in anemia. J. Infect. Dis. 192 (2005) 2160-2170
50. Goud G.N., et al. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. Vaccine 23 (2005) 4754-4764
51. WHO (2005) Report of the third global meeting of the partners for parasite control: deworming for health and development. WHO/CDS/CPE/PVC/2005.14
52. Albonico M., et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 538-541
53. Christian P., et al. Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal. Lancet 364 (2004) 981-983
54. Editorial (2004) Thinking beyond deworming. Lancet 364, 1993-1994
55. Elias D. Are intestinal helminths risk factors for developing active tuberculosis?. Trop. Med. Int. Health 11 (2006) 551-558
56. Nacher M., et al. Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. J. Parasitol. 88 (2002) 55-58
57. Spiegel A., et al. Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 198-199
58. Nacher M., et al. Ascaris lumbricoides infection is associated with protection from cerebral malaria. Parasite Immunol. 22 (2000) 107-113
59. Stephenson L.S., et al. Controlling intestinal helminths while eliminating lymphatic filariasis. Parasitology 121 Suppl. (2000) S1
60. Hopkins D.R., et al. Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria. Am. J. Trop. Med. Hyg. 67 (2002) 266-272
61. Utzinger J., and de Savigny D. Control of neglected tropical diseases: integrated chemotherapy and beyond. PLoS Med 3 (2006) e112
62. Brooker S., et al. Towards an atlas of human helminth infection in sub-Saharan Africa: the use of geographical information systems (GIS). Parasitol. Today 16 (2000) 303-307
63. Lengeler C., et al. Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. Bull. World Health Organ. 80 (2002) 235-242
64. Kabatereine N.B., et al. Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control. Trop. Med. Int. Health 9 (2004) 372-380
65. Brooker S., et al. Rapid assessment of Schistosoma mansoni: the validity, applicability and cost-effectiveness of the Lot Quality Assurance Sampling method in Uganda. Trop. Med. Int. Health 10 (2005) 647-658
66. Weil G.J., et al. The ICT Filariasis Test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol. Today 13 (1997) 401-404
67. Raso G., et al. An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6934-6939
68. Horton J., et al. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 121 Suppl. (2000) S147-S160
69. Na-Bangchang K., et al. Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 335-345
70. Tanner M. Evaluation and monitoring of schistosomiasis control. Trop. Med. Parasitol. 40 (1989) 207-213
71. Keiser J., et al. Reducing the burden of malaria in different eco-epidemiological settings with environmental management: a systematic review. Lancet Infect. Dis. 5 (2005) 695-708
72. WHO (2000) Preparing and implementing a national plan to eliminate lymphatic filariasis. WHO/CDS/CPE/CEE/2000.15
73. Michael E., et al. Mathematical modelling and the control of lymphatic filariasis. Lancet Infect. Dis. 4 (2004) 223-234
74. Hagan P., et al. Schistosomiasis control: keep taking the tablets. Trends Parasitol. 20 (2004) 92-97
75. Danso-Appiah A., and de Vlas S.J. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol. 18 (2002) 125-129
76. Albonico M., et al. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull. World Health Organ. 81 (2003) 343-352
77. Armstrong Schellenberg J.R.M., et al. Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in Tanzania. Lancet 364 (2004) 1583-1594
78. Task Force on Health Systems Research (2004) Informed choices for attaining the Millennium Development Goals: towards an international cooperative agenda for health-systems research. Lancet 364, 997-1003
79. WHO (2004) The World Health Report 2004: Changing History, WHO
80. Brady, M.A. et al. (2006) Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol. DOI: 10.1016/j.pt.2006.05.007
81. Mohammed, K.A. et al. (2006) Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme. Trends Parasitol. DOI: 10.1016/j.pt.2006.05.010
82. Hotez, P.J. et al. (2006) New technologies for the control of human hookworm infection. Trends Parasitol. DOI: 10.1016/j.pt.2006.05.004